《华西药学杂志》2019~2021年的退稿情况分析  

Analysis of manuscripts rejection of West China Journal of Pharmaceutical Sciences during 2019-2021

作　　者：李容[1] 杨宇[1] 杨红芸[1] LI Rong;YANG Yu;YANG Hongyun(West China School of Pharmacy,Sichuan University,Chengdu,Sichuan,610041 P.R.China)

机构地区：[1]四川大学华西药学院,四川成都610041

出　　处：《华西药学杂志》2022年第6期701-703,共3页West China Journal of Pharmaceutical Sciences

基　　金：四川大学科研基金(编号:17H1104)。

摘　　要：目的评价《华西药学杂志》2019~2021年稿件的审稿及退稿情况,为作者和读者提供参考。方法采用Excel表统计《华西药学杂志》2019~2021年收到的药学类论文的录用及退稿情况,分析主要退稿原因。结果近三年共收到投稿论文共4873篇,退稿论文共4384篇,退稿率为89.97%。主要退稿原因为稿件不符合刊登范围(33.12%),其次为一稿多投、代写代投(26.12%)和稿件质量不达标(21.26%)。结论当前投稿最突出的问题为复制比例过高、稿件质量不高,一稿多投、代写代投情况较多。作者撰写论文时应加强论文的实用性和科学性,提高论文水平,以期增加投稿的接收率。OBJECTIVE To evaluate the rejection of manuscripts in West China Journal of Pharmaceutical Sciences during 2019-2021,so as to provide reference for the authors and readers.METHODS The employment and rejection of pharmaceutical papers received by West China Journal of Pharmaceutical Sciences during 2019-2021 were statistically analyzed with Excel,and the main reasons for rejection were analyzed.RESULTS 4873 papers were received and 4384 papers were rejected in recent three years,with a rejection rate of 89.97%.The main reasons for the rejection were the manuscripts do not conform to the published scope(33.12%),followed by multiple contributions,proxy contributions(26.12%)and substandard manuscript quality(21.26%).CONCLUSION The most prominent problems of contributions are the high proportion of copies,low quality of contributions,multiple contributions for one manuscript,and more proxy contributions.The author should strengthen the practicability and scientificity of the paper when writing the paper,and improve the level of the paper in order to increase the rate of reception rate.

关 键 词：药学 华西药学杂志 投稿 论文质量 退稿 

分 类 号：G232[文化科学]